Additionally, these cells secreted numerous inflammatory cytokines, such as interleukin (IL)-6 and tumor necrosis factor-alpha (TNF-α) [4,5] which orchestrated inflammation, radiographic progression of RA and were, therefore, therapeutic targets of current RA management [6]. This evidence concerns the gene TNF and rheumatoid arthritis.